How does thyme intake potentially influence the efficacy of Acetylcholinesterase (AChE) inhibitors used for Alzheimer’s Disease?

Answer

Thyme may increase the effects and side effects associated with these inhibitors

Thyme's broad array of biological activities extends to interactions with various neurotransmitter systems, leading to moderate interaction risks with specific classes of prescription drugs. Acetylcholinesterase (AChE) inhibitors are commonly used in the management of Alzheimer’s disease to increase levels of the neurotransmitter acetylcholine in the brain. When thyme is introduced alongside these medications, there is a potential for synergy or potentiation. The interaction suggests that the effects, as well as the potential side effects, associated with the AChE inhibitors may be heightened or increased when thyme is consumed concurrently. This overlapping mechanism warrants caution and professional consultation for individuals on this specific Alzheimer's regimen.

How does thyme intake potentially influence the efficacy of Acetylcholinesterase (AChE) inhibitors used for Alzheimer’s Disease?
dietHerbwarningconsumptionthyme